Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?
- PMID: 31533893
- PMCID: PMC11949074
- DOI: 10.1016/j.hpb.2019.08.012
Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?
Abstract
Background: Hepatocellular carcinoma (HCC) de-differentiation is thought to correlate with size, therefore well-differentiated HCC ≥3 cm are considered rare and not fully understood.
Methods: Patients who underwent hepatectomy for HCC between 1998-2016 were retrospectively analyzed. Patient's characteristics and recurrence-free (RFS) and overall (OS) survival were compared between those with atypical- (well-differentiated-HCC ≥3 cm) and typical-HCC (moderate-to-poorly-differentiated HCC ≥3 cm).
Results: Of 176 patients included in this study, 37 (21%) had atypical-HCC. Patients with atypical-HCC were less likely to be Asian ethnicity (3% vs. 17%, p = 0.062), have lower rate of viral infection (14% vs. 43%, p = 0.003), cirrhosis (8% vs. 27%, p = 0.015). The tumors were less likely to demonstrate vascular invasion (30% vs. 59%, p = 0.002), and were associated with a lower alpha-fetoprotein level (3.5 ng/ml vs. 33.2 ng/ml, p < 0.001). Patients with atypical-HCC had a longer RFS (5-y RFS: 58.3% vs. 35.7%, p = 0.016) and OS (5-y OS: 79.1% vs 53.3%, p = 0.029) as compared to those with typical-HCC following univariate analysis, however this did not appear following multivariate analysis.
Conclusion: Patients with atypical-HCC have different characteristic in terms of epidemiology, etiology, cirrhosis and vascular invasion as compared to typical-HCC. The etiology of atypical-HCC may be non-alcoholic fatty liver disease-related and/or malignant transformation of hepatocellular adenoma.
Copyright © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
Figures



Similar articles
-
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 29262506 Chinese.
-
Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy.Sci Rep. 2021 Aug 11;11(1):16343. doi: 10.1038/s41598-021-95835-5. Sci Rep. 2021. PMID: 34381132 Free PMC article.
-
Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis.J Gastrointest Cancer. 2019 Dec;50(4):808-815. doi: 10.1007/s12029-018-0152-x. J Gastrointest Cancer. 2019. PMID: 30117090
-
Characteristics and Outcomes of Elderly Hepatocellular Carcinoma Patients following Surgical Resection: Systematic Review and Meta-Analysis.Dig Dis. 2025;43(2):206-214. doi: 10.1159/000530101. Epub 2023 Mar 13. Dig Dis. 2025. PMID: 36913917 Free PMC article.
-
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.J Surg Oncol. 2002 Dec;81(4):195-202. doi: 10.1002/jso.10178. J Surg Oncol. 2002. PMID: 12451624 Review.
Cited by
-
A combined model based on radiomics features of Sonazoid contrast-enhanced ultrasound in the Kupffer phase for the diagnosis of well-differentiated hepatocellular carcinoma and atypical focal liver lesions: a prospective, multicenter study.Abdom Radiol (NY). 2024 Oct;49(10):3427-3437. doi: 10.1007/s00261-024-04253-4. Epub 2024 May 14. Abdom Radiol (NY). 2024. PMID: 38744698
-
Antitumoral and Anti-inflammatory Roles of Somatostatin and Its Analogs in Hepatocellular Carcinoma.Anal Cell Pathol (Amst). 2021 Nov 27;2021:1840069. doi: 10.1155/2021/1840069. eCollection 2021. Anal Cell Pathol (Amst). 2021. PMID: 34873567 Free PMC article. Review.
-
Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas.JHEP Rep. 2021 Jun 29;3(4):100326. doi: 10.1016/j.jhepr.2021.100326. eCollection 2021 Aug. JHEP Rep. 2021. PMID: 34368664 Free PMC article.
References
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. 2010;127(12):2893–2917. - PubMed
-
- Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet (London, England). 2012;379(9822):1245–1255. - PubMed
-
- Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7(3):462–503. - PubMed
-
- Nam SW, Park JY, Ramasamy A, et al. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology (Baltimore, Md). 2005;42(4):809–818. - PubMed
-
- Kudo M. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity. Intervirology. 2004;47(3–5):227–237. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical